Furthermore, the S621G mutation in cyclin F prevents phosphorylation by CK2 and confers elevated Lys48-ubiquitylation activity, a hallmark of ALS/FTD pathology. The gene discussed is CCNF; the disease is amyotrophic lateral sclerosis.